Ackermann Michael 13D and 13G filings for Tarsus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:45 pm Sale |
2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Ackermann Michael | 1,261,666 6.100% |
-205,354 (-14.00%) |
Filing |
| 2021-02-12 5:19 pm Purchase |
2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Ackermann Michael | 1,467,020 7.070% |
1,467,020 (New Position) |
Filing |